Efficacy and safety of orally/sublingually, intranasally and intraperitoneally administered recombinant murine interferon in the treatment of murine encephalomyocarditis virus.

G. Sonnenveld, H. Tovey, H. Schellekens, K.S. Kinney, T. Belay, D.S. Morton, C.E. Austin, M. Reitman, T.A. Fong, H.S. Vaughan

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)539-545
Number of pages7
JournalJournal of interferon & cytokine research
Volume21
Issue number7
Publication statusPublished - 2001

Cite this